Who makes CSII,ALA,MET,RSG?

CSII,ALA,MET,RSG is developed by Sun Yat-sen University.

What development phase is CSII,ALA,MET,RSG in?

CSII,ALA,MET,RSG is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

CSII,ALA,MET,RSG

Sun Yat-sen University · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	CSII,ALA,MET,RSG
Sponsor	Sun Yat-sen University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CSII,ALA,MET,RSG CI brief — competitive landscape report
CSII,ALA,MET,RSG updates RSS · CI watch RSS
Sun Yat-sen University portfolio CI